A case report of greater saphenous vein thrombosis in a patient with coronavirus (COVID-19) infection

Abstract In December 2019, the World Health Organization (WHO) announced a series of pneumonia cases caused by an unknown origin, discovered in Wuhan, China. A dangerous virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a disease named acute respiratory syndrome, which...

Full description

Bibliographic Details
Published in:Tropical Diseases, Travel Medicine and Vaccines
Main Authors: Negin Hesam-Shariati, Poya Fatehi, Fardin Fathi, Morteza Abouzaripour, Mohammad Bakhtiar Hesam Shariati
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2021
Subjects:
Online Access:https://doi.org/10.1186/s40794-021-00131-9
https://doaj.org/article/2ecbe160507b475aa9bfad8b0c8dc3dc
Description
Summary:Abstract In December 2019, the World Health Organization (WHO) announced a series of pneumonia cases caused by an unknown origin, discovered in Wuhan, China. A dangerous virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a disease named acute respiratory syndrome, which was later popularly called coronavirus infection (COVID-19). Patients with acute COVID-19 are at high risk of thrombosis in various blood vessels due to hypercoagulability, blood stasis, and endothelial damage. In this study, we present a case report of a patient with COVID-19, who was hospitalized in one of the hospitals in Sanandaj, Iran. There were symptoms of fever, chills, muscle aches, cough, and tachycardia. Laboratory tests showed high levels of CRP, ESR, Ferritin CLIA, LDH and D-Dimer in this patient. Doppler ultrasound of the patient also revealed an abnormal finding, thrombosis in the right greater saphenous vein. This suggests that COVID-19 may lead to other negative effects through damage to blood vessels.